| Yonatan Serlin, Alon Friedman and Uwe Heinemann. The Blood-Brain Barrier, In: HomeostaticControl of Brain Function. Boison D, Masino SA, eds. Oxford University Press (2015).
| | Dreier JP, Reiffurth C, Woitzik J, Hartings JA, Drenckhahn C, Windler C, Friedman A, MacVicar B, Herreras A. Neurovascular Events After Subarachnoid Hemorrhage: Towards Experimental and Clinical Standardization. In: Fandino J, Marbacher S, Fathi A-R, Muroi C, Keller E, editors. Cham: Springer International Publishing; 2015. p. 137–40.
| | Gutnick, M.J. and Friedman, A.1986, Synaptic and intrinsic echanisms of synchronization and epileptogenesis in the neocortex. Exp. Brain Research suppl. 14: 327-335.
| | Kaufer, D., Friedman, A., Sternfeld, M., Seidman, S., Beeri, R. Andres, C., and Soreq, H. 1996, Central and peripheral consequences of cholinergic imbalance in Alzheimer’s disease. In: Alzheimer Disease: From Molecular Biology to Therapy. Eds: R. Becker and E. Giacobini. Birkahauser, Boston Inc. pp. 153-158.
| | Soreq, H., Kaufer, D., Friedman, A. and Glick, D. 2000, “Blood-Brain-Barrier Modulation and Low-Level Exposure to Xenobiotics”. In: Chemical Warfare Agents: Low Level Toxicity”. S.M. Somani and J.A. Romano, Eds., CRC Press, Boca Raton, FL pp. 121-144.
| | Soreq, H., Kaufer, D., Shelef, I., Golan, H., Tomkins, O., Glick, D., Reichenthal, E. and Friedman, A. 2002, The molecular biology of Blood Brain Barrier disruption under stress. In: Brain Disease: Therapeutic strategies and repair. O. Abramsky, A. Miller and G. Said, Eds., Martin Dunitz, Publishers, pp. 231-238.
| | Avivi, E., Tomkins, O., Korn, A., Pavlovsky, L., Shelef, I. and Friedman, A. 2004, Persistent Blood-Brain-Barrier Disruption in Humans: A Window to Neurodegenerative Diseases, In: Silman, I., Fisher, A., Anglister, L. Michaelson, D. and Soreq, H. (eds.) Cholinergic Mechanisms, Taylor & Francis, London. pp. 423 – 429.
| | Browne, R.O., Pavlovsky, L., and Friedman, A. 2004, Muscarinic Neuromodulation in the Hippocampus and Parahippocampal Region. In: Silman, I., Fisher, A., Anglister, L. Michaelson, D. and Soreq, H. (eds.) Cholinergic Mechanisms, Taylor & Francis, London. pp. 499-507.
| | Alon Friedman and Lev Pavlovsky, 2009. The Cholinergic Model for PTSD: From acute stress to PTSD, From Neuron to Network and Behavior. In: STRESS: from molecules to behavior. A comprehensive analysis of the neurobiology of stress responses. Soreq, H., Friedman, A. and Kaufer. D (eds.) Chap 15. Pp. 283-296.
| | Jonathan E. Cohen, Gabriel Zimmermann, Alon Friedman and Hermona Soreq. 2012. Genomic implications of anticholinesterase sensitivities. Anticholine sterase Pesticides: Metabolism, Neurotoxicity and Epidemiology. Editors: Tetsuo Satoh and Ramesh C. Gupta. John Wiley, in press. | | Alon Friedman and Uwe Heinemann. 2012. Role of blood-brain barrier injury in epileptogenesis. Jasper's Basic Mechanisms of the Epilepsies. Editors: Jeffrey L. Noebels, Massimo Avoli, Michael A. Rogawski, Richard W. Olsen and Antonio V. Delgado-Escueta, Summary published in Epilepsia, 51 (Suppl. 5): 34, 2010.
| | Yoash Hassidim, Ofer Prager, Ilan Shelf and Alon Friedman. 2012. Assessment of Blood-brain barrier breakdown. In: Animal Models of Acute Neurological Injuries. Jun Chen, Xio-Ming Xu, Zao C. Xu and John H. Zhang (Eds.) Humana Press, Colune 1, pp. 401-5.
| | Alon Friedman and Mireille Lerner-Natoli. 2012. Targtes for antiepileptogenesis: blood-brain barrier and angiogenesis. Therapeutic targets and perspectives in the pharmacological treatment of epilepsy. Editor: Holger Lerche and Heidrun Potschka. UNI-MED Science.
|
|